Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Felbamate urolithiasis.

S P Sparagana1, W R Strand, R C Adams

  • 1Division of Child Neurology, Texas Scottish Rite Hospital for Children, Dallas, USA. SSPARAGA@TSRH.org

Epilepsia
|June 1, 2001
PubMed
Summary

Felbamate (FBM) urolithiasis is a rare condition that can cause painful hematuria and urinary obstruction. Discontinuation of FBM and managing contributing factors can resolve FBM stones.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Using the Analytic Hierarchy Process To Derive Health State Utilities From Ordinal Preference Data.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Somatosensory evoked potential monitoring of peripheral nerves during external fixation for limb lengthening and correction of deformity in children.

The Journal of bone and joint surgery. British volume·2012
Same author

A blood transfusion service; dangers and safeguards.

Anesthesiology·2010
Same author

A CASE OF OBSTRUCTION OF THE STOMACH BY AN IMPACTED MASS OF HAIR.

Canadian Medical Association journal·2010
Same author

THE PRESENT STATUS OF INTRAVENOUS ADMINISTRATION OF PENTOTHAL SODIUM IN INSTITUTIONAL AND PRIVATE PRACTICE.

Canadian Medical Association journal·2010
Same author

Intravenous anesthesia.

Anesthesiology·2010

Area of Science:

  • Nephrology
  • Urology
  • Pharmacology

Background:

  • Felbamate (FBM) is an anticonvulsant medication.
  • Urolithiasis, or kidney stone formation, is a common condition with various etiologies.
  • The potential for FBM to cause urolithiasis has been an area of clinical interest.

Observation:

  • A 15-year-old male presented with painful hematuria, bilateral ureteral obstruction, and urinary retention.
  • Diagnostic imaging revealed kidney, bladder, and ureteral stones.
  • Ureteral stent placement was necessary to alleviate the obstruction.

Findings:

  • Chemical analysis identified the stones as composed of felbamate (FBM).
  • Discontinuation of FBM therapy led to the cessation of stone formation.
  • Contributing factors may include high FBM dosage, polypharmacy, and pre-existing stone risk factors.

Implications:

  • This case highlights the potential for felbamate (FBM) to cause urolithiasis.
  • Crystalluria may serve as an early indicator of FBM-induced stone formation.
  • Clinicians should consider FBM urolithiasis in patients presenting with unexplained stones, especially those on FBM therapy.

Related Experiment Videos